BCHE and early-onset autosomal dominant Alzheimer disease: <b>Background</b>: Cholinesterase inhibitors (ChEIs) are commonly prescribed for the treatment of Alzheimer's disease (AD) and achieve long-term benefits for cognition and survival in real-world settings.